These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 11902741
1. Acute megakaryoblastic leukemia after transient myeloproliferative disorder with clonal karyotype evolution in a phenotypically normal neonate. Polski JM, Galambos C, Gale GB, Dunphy CH, Evans HL, Batanian JR. J Pediatr Hematol Oncol; 2002 Jan; 24(1):50-4. PubMed ID: 11902741 [Abstract] [Full Text] [Related]
2. A 15q24 microdeletion in transient myeloproliferative disease (TMD) and acute megakaryoblastic leukaemia (AMKL) implicates PML and SUMO3 in the leukaemogenesis of TMD/AMKL. Haemmerling S, Behnisch W, Doerks T, Korbel JO, Bork P, Moog U, Hentze S, Grasshoff U, Bonin M, Rieß O, Janssen JW, Jauch A, Bartram CR, Reinhardt D, Koch KA, Bandapalli OR, Kulozik AE. Br J Haematol; 2012 Apr; 157(2):180-7. PubMed ID: 22296450 [Abstract] [Full Text] [Related]
3. Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome. Greene ME, Mundschau G, Wechsler J, McDevitt M, Gamis A, Karp J, Gurbuxani S, Arceci R, Crispino JD. Blood Cells Mol Dis; 2003 Apr; 31(3):351-6. PubMed ID: 14636651 [Abstract] [Full Text] [Related]
4. Chromosome 7 abnormalities in acute megakaryoblastic leukemia associated with Down syndrome. Kobayashi K, Usami I, Kubota M, Nishio T, Kakazu N. Cancer Genet Cytogenet; 2005 Apr 15; 158(2):184-7. PubMed ID: 15796967 [Abstract] [Full Text] [Related]
5. Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome. Nikolaev SI, Santoni F, Vannier A, Falconnet E, Giarin E, Basso G, Hoischen A, Veltman JA, Groet J, Nizetic D, Antonarakis SE. Blood; 2013 Jul 25; 122(4):554-61. PubMed ID: 23733339 [Abstract] [Full Text] [Related]
6. Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder. Cushing T, Clericuzio CL, Wilson CS, Taub JW, Ge Y, Reichard KK, Winter SS. J Pediatr; 2006 May 25; 148(5):687-9. PubMed ID: 16737888 [Abstract] [Full Text] [Related]
7. Distinct clones are associated with the development of transient myeloproliferative disorder and acute megakaryocytic leukemia in a patient with Down syndrome. Kanegane H, Watanabe S, Nomura K, Xu G, Ito E, Miyawaki T. Int J Hematol; 2007 Oct 25; 86(3):250-2. PubMed ID: 17988992 [Abstract] [Full Text] [Related]
8. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. Rainis L, Bercovich D, Strehl S, Teigler-Schlegel A, Stark B, Trka J, Amariglio N, Biondi A, Muler I, Rechavi G, Kempski H, Haas OA, Izraeli S. Blood; 2003 Aug 01; 102(3):981-6. PubMed ID: 12649131 [Abstract] [Full Text] [Related]
10. Acute megakaryoblastic leukemia following transient myeloproliferative disorder in a patient without Down syndrome. Brissette MD, Duval-Arnould BJ, Gordon BG, Cotelingam JD. Am J Hematol; 1994 Dec 01; 47(4):316-9. PubMed ID: 7977305 [Abstract] [Full Text] [Related]
12. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome. Boztug H, Schumich A, Pötschger U, Mühlegger N, Kolenova A, Reinhardt K, Dworzak M. Cytometry B Clin Cytom; 2013 Dec 01; 84(6):370-8. PubMed ID: 23450818 [Abstract] [Full Text] [Related]
17. A neonate with a unique non-Down syndrome transient proliferative megakaryoblastic disease. Bertrums EJ, Buijs A, van Grotel M, Dors N, de Rooij JD, de Haas V, Hopman S, Jongmans MC, Zwaan CM, van den Heuvel-Eibrink MM. Pediatr Blood Cancer; 2017 Mar 01; 64(3):. PubMed ID: 27667142 [Abstract] [Full Text] [Related]